Itziar Canamasas
Global Head of Oncology, SVP at Boehringer Ingelheim | Basel Metropolitan Area, Switzerland
Itziar Canamasas’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Strategic Advisor and Chairwoman at AtG Therapeutics in April 2024 - Present
Global Head of Oncology, SVP at Boehringer Ingelheim in May 2024 - Present
Chief Executive Officer at AtG Therapeutics in February 2023 - April 2024
Member Board Of Directors at ALX Oncology in April 2022 - April 2024
Strategic Advisor at AtG Therapeutics in August 2022 - January 2023
Head of Oncology Europe, Middle East and Africa at Bayer Pharmaceuticals in August 2020 - July 2022
Board Member at Irish Pharmaceutical Healthcare Association in May 2019 - August 2020
Managing Director Bayer Ltd | Board Member at Bayer Pharmaceuticals in May 2017 - July 2020
Council Member German Irish Chamber at German-Irish Chamber of Industry & Commerce in October 2017 - July 2020
VP Global Marketing Oncology - Global Leadership Circle at Bayer Pharmaceuticals in March 2014 - April 2017
VP Global Marketing Oncology at Bayer Pharmaceuticals in April 2012 - February 2014
VP Regional Marketing Oncology Europe and Canada at Bayer Pharmaceuticals in January 2010 - March 2012
Director Regional Marketing Oncology Europe at Bayer Pharmaceuticals in July 2008 - December 2009
Deputy Director Regional Marketing Oncology Europe at Bayer Pharmaceuticals in July 2007 - June 2008
Associate Director Global Marketing Oncology at Bayer Pharmaceuticals in January 2006 - June 2007
Marketing Manager Global Marketing Oncology at Bayer Pharmaceuticals in January 2005 - December 2005
International Management Trainee at Bayer Pharmaceuticals in September 2001 - December 2004
IMD Business School, Entrepreneurship, January 2017
Harvard Business School, Executive Leadership, January 2015
IMD Business School, Executive Business, January 2011
AtG Therapeutics is a pre-clinical stage drug development company specialised in the discovery of targets of tumor adaptation vulnerabilities and the development of therapeutics and biomarkers to treat advanced cancer.
Discover more about Boehringer Ingelheim
Chief Executive | Health & Innovation Ecosystems | EU Funding & Public‑Private Partnerships
Funding & Financial Strategy Manager at AtG Therapeutics
(Jul 2025 – Present)
Co-Founder & CSO at AtG Therapeutics, and Senior Group Leader at Catalan Institute of Oncology - IDIBELL
At AtG Therapeutics we are developing a novel anticancer treatment with its patient selection biomarker for patients with advanced cancers.
Drug Discovery and Development Expert. Chief Development Officer at Medchemfarma
Chief Development Officer at Medchemfarma S.L.
(Feb 2026 – Present)
• Pharmacist • Drug Discovery • Research Scientist en AtG Therapeutics
Research Scientist at AtG Therapeutics
(Nov 2024 – Present)
Co-founder & COO at AtG Therapeutics
Co-Founder & COO at AtG Therapeutics at AtG Therapeutics
(Mar 2023 – Present)
Cancer Drug Discovery & Therapeutic Innovation
As Head of the Tumor Adaptation Laboratory at AtG Therapeutics, I lead a dynamic R&D team dedicated to drug discovery and early preclinical drug development with the aim of advancing our portfolio of therapies to clinical trials and improving the lives of those patients affect...
What is Itziar Canamasas email address?
Email Itziar Canamasas at [email protected] and [email protected]. This email is the most updated Itziar Canamasas's email found in 2026.
How to contact Itziar Canamasas?
To contact Itziar Canamasas send an email to [email protected] or [email protected].
What company does Itziar Canamasas work for?
Itziar Canamasas works for Boehringer Ingelheim.
What is Itziar Canamasas's role at Boehringer Ingelheim?
Itziar Canamasas is Global Head of Oncology, SVP
What industry does Itziar Canamasas work in?
Itziar Canamasas works in the Pharmaceuticals industry.
